Lewis Ben, Hoffman Lauren A, Nixon Sara Jo
University of Florida, Department of Psychiatry, Gainesville, FL 32610, USA.
University of Florida, Department of Psychiatry, Gainesville, FL 32610, USA.
Drug Alcohol Depend. 2014 Dec 1;145:127-33. doi: 10.1016/j.drugalcdep.2014.10.003. Epub 2014 Oct 18.
Available evidence indicates women with substance use disorders may experience more rapid progression through usage milestones (telescoping). The few investigations of sex differences in treatment-seeking populations often focus on single substances and typically do not account for significant polysubstance abuse. The current study examined sex differences in a heterogeneous sample of treatment seeking polysubstance users. We examined patterns of drug use, age at drug use milestones (e.g., initial use, regular use), and progression rates between milestones. Nicotine and alcohol use were also evaluated.
Participants (n = 543; 288 women) completed personal histories of substance use, including chronicity, frequency, and regularity, as well as inventories assessing affect, and intellectual ability.
Rates of drug use and milestone ages varied by sex and specific drug. Analyses suggested pronounced telescoping effects for pain medication and marijuana, with women progressing more rapidly through usage milestones.
Our data were generally supportive of telescoping effects, although considerable variance in progression measures was noted. The contrast between the marked telescoping observed in pain medication use and the absence of telescoping in other opioids was of particular interest. The discrepancy in telescoping effects, despite shared pharmacologies, suggests the need for further work examining underlying psychosocial factors. These results highlight that the specific sample population, substance, and outcome measure should be carefully considered when interpreting sex differences in substance use.
现有证据表明,患有物质使用障碍的女性可能会更快地经历使用阶段的进展(阶段缩短)。对寻求治疗人群中性别差异的少数研究通常只关注单一物质,且通常未考虑到严重的多物质滥用情况。本研究调查了寻求治疗的多物质使用者异质样本中的性别差异。我们研究了药物使用模式、达到药物使用阶段的年龄(例如初次使用、经常使用)以及各阶段之间的进展速度。还评估了尼古丁和酒精的使用情况。
参与者(n = 543;288名女性)完成了物质使用的个人史,包括慢性程度、频率和规律性,以及评估情绪和智力能力的量表。
药物使用率和达到各阶段的年龄因性别和特定药物而异。分析表明,在止痛药和大麻方面存在明显的阶段缩短效应,女性在使用阶段的进展更快。
我们的数据总体上支持阶段缩短效应,尽管在进展指标方面存在相当大的差异。在止痛药使用中观察到的明显阶段缩短与其他阿片类药物中不存在阶段缩短之间的对比尤其令人感兴趣。尽管药理学相同,但阶段缩短效应的差异表明需要进一步研究潜在的心理社会因素。这些结果强调,在解释物质使用中的性别差异时,应仔细考虑特定的样本群体、物质和结果指标。